| Effect of procedure and coronary lesion characteristics on clinical outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the … M Kerneis, CM Gibson, G Chi, R Mehran, F AlKhalfan, U Talib, ... JACC: Cardiovascular Interventions 11 (7), 626-634, 2018 | 28 | 2018 |
| Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors T Nafee, A Aslam, G Chi, S Pahlavani, D Nimri, AR Kuchkuntla, U Talib, ... Expert Review of Cardiovascular Therapy 15 (4), 237-245, 2017 | 19 | 2017 |
| Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention M Kerneis, U Talib, T Nafee, Y Daaboul, S Pahlavani, A Pitliya, ... Progress in Cardiovascular Diseases 60 (4-5), 524-530, 2018 | 14 | 2018 |
| COVID-19 among hospitalized patients with kidney disease: Experience at a US Midwestern academic medical center Y Caliskan, S Pahlavani, A Schnell, AA Memon, FA Al Rub, U Elewa, ... Turkish journal of nephrology 31 (3), 230, 2022 | 4 | 2022 |
| Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple … G Chi, A Jamil, M Radulovic, U Jamil, MA Balouch, J Marszalek, Z Karimi, ... Medical Hypotheses 114, 40-44, 2018 | 4 | 2018 |
| Tuberculin skin test conversion among individuals with human immunodeficiency virus infection on antiretroviral therapy in a referral teaching hospital, Tehran, Iran M Talebi-Taher, L Abbasian, SN Alavi-Niakou, SA Javad-Moosavi, ... Tanaffos 16 (3), 201, 2017 | 3 | 2017 |
| Suppurative thrombophlebitis of the inferior vena cava resolved with intravenous antibiotic therapy: a case report M Talebi-Taher, B Naghavi, S Hajsadeghi, A Iranpour, SM Pahlavani The Journal of Tehran University Heart Center 13 (3), 132, 2018 | 1 | 2018 |
| High-density lipoprotein-targeted therapy for coronary heart disease: Is the HDL hypothesis operational or defunct? G Chi, Z Karimi, F Kahe, M Jafarizade, S Pahlavani, A Jamil, A Kalayci Current Trends in Biomedical Engineering & Biosciences 12 (2), 56-60 Volume6 12, 2018 | 1 | 2018 |
| COVID-19 among hospitalized patients with kidney disease: Experience at a Midwestern medical center KL Lentine, S Pahlavani, Y Caliskan, AA Schnell, NE Marino, AX Taylor, ... Journal of the American Society of Nephrology, 72-72, 2021 | | 2021 |
| COVID-19 AMONG HOSPITALIZED PATIENTS WITH KIDNEY DISEASE: EXPERIENCE AT AN ACADEMIC MEDICAL CENTER S Pahlavani, A Schnell, Y Caliskan, U Elewa, N Marino, A Taylor, ... American Journal of Kidney Diseases, 633-634, 2021 | | 2021 |
| COMPARATIVE EFFICACY AND SAFETY OF RIVAROXABAN-BASED DUAL-PATHWAY ANTITHROMBOTIC THERAPY VERSUS DUAL ANTIPLATELET THERAPY: A POOLED ANALYSIS OF CONTEMPORARY RANDOMIZED … A Jamil, U Jamil, M Faggioni, J Marszalek, S Mehrsefat, S Pahlavani, ... Journal of the American College of Cardiology 71 (11S), A38-A38, 2018 | | 2018 |
| Suppurative Thrombophlebitis of the Inferior Vena Cava Resolved with Intravenous Antibiotic Therapy: A Case Report (Case Report) TM TALEBI, B Naghavi, A IRANPOUR, SM Pahlavani THE JOURNAL OF TEHRAN UNIVERSITY HEART CENTER 13 (3), 132-135, 2018 | | 2018 |
| Commentary: Extended-Duration betrixaban reduces the risk of stroke versus standard-Dose enoxaparin among hospitalized medically Ill patients T Nafee, D Nimri, G Chi, S Korjian, Y Daaboul, D Arbetter, M Yee, P Jain, ... Journal of Neurology & Neuromedicine 2 (5), 2017 | | 2017 |
| Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI T Nafee, G Chi, F AlKhalfan, S Korjian, Y Daaboul, S Pahlavani, U Talib, ... | | |
